COMPARATIVE EFFECTIVENESS AND SAFETY BETWEEN APIXABAN AND RIVAROXABAN IN OLDER PATIENTS WITH ATRIAL FIBRILLATION: A POPULATION-BASED COHORT STUDY

被引：0
|
作者：
Shurrab, Mohammed [1 ]
Austin, Peter [1 ]
Jackevicius, Cynthia [1 ]
Tu, Karen [1 ]
Qiu, Feng [1 ]
Healey, Jeff S. [1 ]
Ko, Dennis T. [1 ]
机构：
[1] Hlth Sci North, Sudbury, ON, Canada
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2024年 / 83卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1001-09
引用
收藏
页码：9 / 9
页数：1
相关论文
共 50 条
  • [31] Effectiveness and Safety of Apixaban versus Rivaroxaban in Patients with Atrial Fibrillation and Type 2 Diabetes Mellitus
    Chowdhury, Krishna Roy
    Michaud, Jonathan
    Yu, Oriana Hoi Yun
    Yin, Hui
    Azoulay, Laurent
    Renoux, Christel
    [J]. THROMBOSIS AND HAEMOSTASIS, 2022, 122 (10) : 1794 - 1803
  • [32] Bleeding in patients with atrial fibrillation treated with dabigatran, rivaroxaban or warfarin: A retrospective population-based cohort study
    Ellis, Martin H.
    Neuman, Tsipora
    Bitterman, Haim
    Dotan, Sari Greenberg
    Hammerman, Ariel
    Battat, Erez
    Eikelboom, John W.
    Ginsberg, Jeffrey S.
    Hirsh, Jack
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2016, 33 : 55 - 59
  • [33] DIRECT COMPARISON OF DABIGATRAN, RIVAROXABAN, AND APIXABAN FOR EFFECTIVENESS AND SAFETY IN NONVALVULAR ATRIAL FIBRILLATION
    Noseworthy, Peter
    Yao, Xiaoxi
    Sangaralingham, Lindsey R.
    Abraham, Neena
    McBane, Robert
    Gersh, Bernard
    Shah, Nilay
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 692 - 692
  • [34] Evaluation of Apixaban safety and effectiveness in morbidly obese patients with atrial fibrillation: a retrospective cohort study
    Khalid Al Sulaiman
    Hisham A. Badreldin
    Ghazwa B. Korayem
    Abeer A. Alenazi
    Faisal Alsuwayyid
    Abdulrahman Alrashidi
    Mohammed Alhijris
    Faisal Almutairi
    Fahad Alharthi
    Ramesh Vishwakarma
    Omar Al Shaya
    Abdulrahman Al Amri
    Saqiba Tayyab
    Abdulkareem M. Al Bekairy
    Ohoud Aljuhani
    [J]. Thrombosis Journal, 20
  • [35] Direct Comparison of Dabigatran, Rivaroxaban, and Apixaban for Effectiveness and Safety in Nonvalvular Atrial Fibrillation
    Noseworthy, Peter A.
    Yao, Xiaoxi
    Abraham, Neena S.
    Sangaralingham, Lindsey R.
    McBane, Robert D.
    Shah, Nilay D.
    [J]. CHEST, 2016, 150 (06) : 1302 - 1312
  • [36] Direct comparisons of effectiveness and safety of treatment with Apixaban, Dabigatran and Rivaroxaban in atrial fibrillation
    Jansson, M.
    Sjalander, S.
    Sjogren, V.
    Renlund, H.
    Norrving, B.
    Sjalander, A.
    [J]. THROMBOSIS RESEARCH, 2020, 185 : 135 - 141
  • [37] Evaluation of Apixaban safety and effectiveness in morbidly obese patients with atrial fibrillation: a retrospective cohort study
    Al Sulaiman, Khalid
    Badreldin, Hisham A.
    Korayem, Ghazwa B.
    Alenazi, Abeer A.
    Alsuwayyid, Faisal
    Alrashidi, Abdulrahman
    Alhijris, Mohammed
    Almutairi, Faisal
    Alharthi, Fahad
    Vishwakarma, Ramesh
    Al Shaya, Omar
    Al Amri, Abdulrahman
    Tayyab, Saqiba
    Al Bekairy, Abdulkareem M.
    Aljuhani, Ohoud
    [J]. THROMBOSIS JOURNAL, 2022, 20 (01)
  • [38] Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation
    Yao, Xiaoxi
    Abraham, Neena S.
    Sangaralingham, Lindsey R.
    Bellolio, M. Fernanda
    McBane, Robert D.
    Shah, Nilay D.
    Noseworthy, Peter A.
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (06):
  • [39] Comparative Safety and Effectiveness of Apixaban Dosing in Patients With Atrial Fibrillation and Severe CKD
    Xu, Yunwen
    Chang, Alex R.
    Inker, Lesley A.
    McAdams-DeMarco, Mara
    Grams, Morgan
    Shin, Jung-Im
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 305 - 305
  • [40] EFFECTIVENESS AND SAFETY OF LOW VERSUS HIGH DOSE RIVAROXABAN AND APIXABAN FOR ATRIAL FIBRILLATION: PROPENSITY SCORE-MATCHED COHORT STUDY
    Perreault, S.
    Dragomir, A.
    Lenglet, A.
    Dorais, M.
    [J]. VALUE IN HEALTH, 2022, 25 (01) : S133 - S133
12345